Drug Eluting Stents

Related by string. drug eluting stents * Drugs . DRUG . drugs : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration / eluted . eluting : CYPHER R Sirolimus eluting . CYPHER ® Sirolimus eluting . Resolute drug eluting / stenting . Stenting : drug coated stents . stents inserted * drug eluting stent implantation . Drug Eluting Stent System . drug eluting stent DES *

Related by context. All words. (Click for frequent words.) 77 Drug Eluting Stent 75 Drug Eluting 75 Bare Metal Stents 74 Carotid Stenting 73 Overactive Bladder 73 Pivotal Trial 73 Coronary Stent 73 Acute Ischemic Stroke 72 Stent Thrombosis 72 Randomized Clinical Trial 71 Unfractionated Heparin 71 Heart Failure Patients 71 Prospective Randomized 71 Acute Myocardial Infarction 71 Rheumatoid Arthritis Patients 71 Clinical Trial Results 70 Surgical Procedures 70 Clinical Outcome 70 Cardiac Resynchronization Therapy 70 Patients Undergoing 70 Cypher Sirolimus 70 FDA Approvals 70 Patient Outcomes 70 Phase III Clinical Trial 70 Pivotal Clinical Trial 70 Carotid 70 Infarct 70 Bare Metal Stent 69 Subgroup Analysis 69 Beta Blocker 69 Stenting 69 Phase III Trial 69 Renal Cell Carcinoma 69 Improves Survival 69 Long Term Efficacy 69 External Defibrillators 69 Patients Treated 69 Less Invasive 69 Acute Heart Failure 69 STENT 69 Percutaneous Coronary Intervention 69 Left Ventricular 69 Fracture Risk 69 Osteoporosis Drugs 69 Stent Implantation 68 Restenosis 68 Thrombectomy 68 Patients Treated With 68 Ischemic Stroke 68 Aneurysm Repair 68 Venous Thromboembolism 68 Obese Patients 68 Clinical Trial Data 68 Meets Primary Endpoint 68 Coronary Artery Bypass Graft 68 CYPHER R Sirolimus Eluting 68 Ventricular Assist Devices 68 Sirolimus Eluting Stent 68 Investigational Agent 68 Statin Therapy 68 Phase 2a Clinical Trial 68 Patient Enrollment 68 Angiographic 68 Neurostimulation 68 Endovascular Treatment 68 Patency 68 Total Knee Arthroplasty 68 Acute Coronary Syndromes 68 Survival Benefit 68 Appears Safe 68 Catheter Ablation 68 Chronic Constipation 68 Elderly Patients 68 Glatiramer Acetate 67 JAK Inhibitor 67 Bivalirudin 67 Liberte TM 67 Bone Graft 67 Patients Enrolled 67 Bioresorbable 67 Chronic Heart Failure 67 Clinical Trial Evaluating 67 Study Evaluating 67 Vertebroplasty 67 Antiplatelet Therapy 67 Aortic Dissection 67 Implantable Cardioverter Defibrillators 67 Severe Sepsis 67 Abciximab 67 Clinical Evaluation 67 Cardiogenic Shock 67 Combination Treatment 67 Aortic Valve 67 Breast Cancer Recurrence 67 stent DES 67 Wound Closure 67 Clinical Efficacy 67 Acute Coronary Syndrome 67 Kidney Transplant Patients 67 Implantable Cardioverter Defibrillator 67 Urinary Incontinence 67 Hypertensive Patients 67 Knee Osteoarthritis 67 Drug Coated Stents 67 Resistant Hypertension 67 Statistically Significant 67 TM Drug Eluting 67 Post Operative 67 Postmenopausal Women 67 Oral Fingolimod 67 Brain Metastases 67 Demonstrates Positive 67 Long Term Outcomes 67 Preclinical Data 66 Fondaparinux 66 Minimally Invasive Treatment 66 Intracranial Aneurysms 66 Infarction 66 Eluting Stent 66 TAXUS ® 66 Improved Survival 66 Pediatric Patients 66 Endarterectomy 66 Neuroprotective Effects 66 Sirolimus eluting 66 Carotid Artery Stenting 66 Paclitaxel Eluting 66 Adjuvant Treatment 66 Coronary Stents 66 Low Dose 66 Disease Progression 66 First Patient Enrolled 66 Lung Cancer Trial 66 Phase IIb Clinical Trial 66 Spinal Fusion 66 Coronary Stent System 66 Platelet Inhibition 66 Diabetic Patients 66 Improve Outcomes 66 Fewer Side Effects 66 Thrombus Aspiration 66 Valsartan 66 Abdominal Stent Graft 66 PROMUS R 66 Randomized Study 66 Demonstrates Significant 66 Recurrent Breast Cancer 66 Prolongs Survival 66 Dual Antiplatelet Therapy 66 Carotid Stent 66 ORLive Presents 66 II Clinical Trial 66 REMINDER ORLive Presents 66 Benign Prostatic Hyperplasia 66 Enoxaparin 66 Skin Lesions 66 Completes Enrollment 66 Expanded Indication 66 Artery Disease 66 TAXUS TM 66 Cardiovascular Outcomes 66 Total Knee Replacement 66 Renal Artery 66 Phase IIb Trial 66 Uterine Fibroid Embolization 66 Eluting Coronary Stent System 66 Adjuvant Chemotherapy 66 Outpatient Setting 66 Surgical Treatment 66 Non Inferiority 66 Cholesterol Lowering Drug 66 ST Elevation Myocardial 66 Endeavor Drug Eluting 66 Embolic Protection Device 66 Meta Analysis 66 Nitinol Stent 66 Treating Depression 66 Implantable Defibrillator 66 Coronary Artery 66 Cardiovascular Events 66 Pulmonary Arterial Hypertension 66 Radiation Dose 66 Randomized Controlled Trials 66 Osteoporosis Treatment 66 ST Segment Elevation 66 Regenerative Cells 66 Phase 2b Clinical Trial 66 Previously Treated 65 MR Angiography 65 Randomized Evaluation 65 Survival Rates 65 Osteoporosis Drug 65 Phase 2a Trial 65 Endovascular Repair 65 First Patient Treated 65 Valve Replacement 65 Pivotal Study 65 Shows Efficacy 65 Coronary Arteries 65 Schizophrenia Treatment 65 PROMUS TM 65 Drug Eluting Coronary Stent 65 Pharmacokinetic Study 65 AneuRx 65 Premenopausal Women 65 Randomized Trials 65 Insulin Pumps 65 Anticoagulants 65 Radical Prostatectomy 65 Pulmonary Artery 65 Hypercholesterolemia 65 Pooled Analysis 65 Embolic Protection 65 PRECISE 65 Relapsed Multiple Myeloma 65 Stent System 65 Hernia Repair 65 Electrophysiology Mapping 65 Induction Therapy 65 Advanced Colorectal Cancer 65 Stent Placement 65 Acute Myocardial 65 Ischemic 65 Thyroid Hormone 65 Sustained Efficacy 65 Adjuvant Therapy 65 Therapy Reduces 65 Dynamic Stabilization 65 BioMatrix 65 Gastric Bypass Surgery 65 Randomized Controlled Trial 65 Hormone Receptor Positive 65 Hepatocellular Carcinoma 65 Embolic 65 Long Term Survival 65 Transcatheter Valve 65 Non Invasive Treatment 65 Spinal Disc 65 Controlled Trial 65 cardiac resynchronisation therapy 65 sirolimus eluting 65 Estrogen Therapy 65 Sirolimus eluting Coronary Stent 65 Pivotal Phase III 65 Anti Clotting Drug 65 Intravascular 65 Left Atrial Appendage 65 Stent Coating 65 NDA Submission 65 Endoprosthesis 65 Relapsing Multiple Sclerosis 65 PROMUS Element Everolimus Eluting 65 See CLINICAL PHARMACOLOGY 65 Bone Metastases 65 Versus Placebo 65 Cholesterol Drug 65 Robotic Assisted 65 Study Shows Significant 65 Metastatic Prostate Cancer 65 Aggressive Drug Evaluation 65 Lung Cancer Survival 65 Diabetic Foot Ulcers 65 Carotid Endarterectomy 65 Antipsychotic Drug 65 Blocked Arteries 65 Percutaneous Tibial Nerve Stimulation 65 Bipolar Depression 65 Efficacious 65 Newly Diagnosed Breast Cancer 65 Contrast Agent 65 Improve Survival 64 superficial femoral 64 Increased Mortality 64 Fungal Infections 64 Transcatheter 64 Laryngeal Cancer 64 Coronary Revascularization 64 Data Suggest 64 Insulin Therapy 64 Breast Cancer Treatment 64 Completes Patient Enrollment 64 Inhaled Insulin 64 TAXUS Stent 64 Cypher Stent 64 Prognostic Value 64 HER2 Positive Breast Cancer 64 Biomaterial 64 Paclitaxel eluting 64 Neoadjuvant Chemotherapy 64 Gout Drug 64 Lymph Node 64 Unstable Angina 64 ® Drug Eluting 64 Stent Restenosis 64 Thrombolysis 64 mechanical thrombectomy 64 Liver Failure 64 Bucindolol 64 TAXUS Element Paclitaxel Eluting 64 Rivaroxaban 64 Balloon Kyphoplasty 64 Peptic Ulcer 64 Stent Grafts 64 Emerging Therapies 64 Inflammatory Arthritis 64 Chronic Sinusitis 64 Investigational Compound 64 Treatment Naïve 64 Inhaled Corticosteroids 64 Kidney Function 64 Balloon Catheter 64 Sirolimus Eluting 64 Analytical Tool 64 WallFlex Biliary RX 64 TM Everolimus Eluting 64 Newly Diagnosed Multiple Myeloma 64 Investigational Treatment 64 Endurant 64 Cervical Spine 64 Rheumatoid Arthritis Drug 64 Refractory Angina 64 Hormonal Contraceptives 64 Treating Chronic 64 Enlarged Prostate 64 AMPLATZER R 64 Phase III Clinical Trials 64 Embolization 64 Bioabsorbable 64 Tacrolimus 64 Low Density Lipoprotein Cholesterol 64 Novel Antibiotic 64 Treating Heart Failure 64 Cardiotoxicity 64 Dose Escalation 64 Heart Stents 64 Breast Density 64 Migraine Drug 64 Proves Effective 64 drug eluting stent DES 64 Image Guided Surgery 64 Minimally Invasive Procedure 64 Premature Infants 64 Gene Variation 64 INFUSE R 64 Hormone Therapy 64 NAVISTAR R 64 Prostate Cancer Treatment 64 ACE Inhibitors 64 Breast Tumors 64 Anticoagulation 64 Complicated Skin 64 Heartburn Drugs 64 Obese Teens 64 Immunosuppression 64 Shows Promising 64 Gastric Cancer 64 Treatment Resistant 64 Intracranial 64 Absorbable 64 Stents 64 Patients Receiving 64 Improves Outcomes 64 Intracerebral Hemorrhage 64 EverFlex 64 Inflammatory Diseases 64 Antiplatelet 64 Lupus Nephritis 64 Lung Cancer Patients 64 Microwave Ablation System 64 Drug Eluting Balloon 64 Antipsychotic Medications 64 Blood Pressure Drug 64 Medtronic Endeavor 64 Urinary Catheter 64 Ventricular 64 Treatment Regimen 64 Endometrial Cancer 64 Inhaled Nitric Oxide 64 Carotid Artery 64 Renal Cancer 64 Targeted Therapies 64 Antitumor Activity 64 Heart Transplant Recipients 64 Stakeholder Opinions 64 Pelvic Organ Prolapse 64 Blood Flow 64 Knee Implant 64 Hip Fractures 64 Prospective Randomized Trial 64 Antifungals 63 Adverse Event 63 Statistical Significance 63 Myocardial Perfusion Imaging 63 Phase III Trials 63 Multicenter Trial 63 Non Invasive 63 Therapy Improves 63 Node Positive 63 Coronary Angiography 63 Colorectal Cancer Patients 63 Well Tolerated 63 Golimumab 63 Initiate Clinical Trial 63 Aortic Valve Replacement 63 Acute Decompensated Heart Failure 63 Cardiac Resynchronization 63 Allografts 63 Surgical Procedure 63 GORE TAG ® 63 Localized Prostate Cancer 63 Treated Patients 63 IND Filing 63 Thromboembolism 63 Drug Shows Promise 63 Multiple Myeloma Patients 63 Vulnerable Plaque 63 Anti Tumor Activity 63 Vertebral Compression Fractures 63 Radiofrequency Ablation 63 Vascular Closure Device 63 Drug Coated Stent 63 Present Preclinical Data 63 Antidepressant Use 63 Anticancer Activity 63 Novel Inhibitor 63 Prevent Stroke 63 Anastomosis 63 Study Showed 63 Reperfusion Injury 63 First Patient Dosed 63 Randomized Clinical Trials 63 Nesiritide 63 Deep Venous Thrombosis 63 drug eluting balloons 63 Phase 2b Study 63 Nerve Stimulation 63 Venous Thrombosis 63 Mitral Regurgitation 63 Suicidality 63 Total Hip Replacement 63 XIENCE 63 Prostate Cancer Patients 63 HeartMate R 63 GORE TAG 63 Mitral Valve Repair 63 Initiates Enrollment 63 Percutaneous Transluminal Coronary Angioplasty 63 Total Hip Arthroplasty 63 Peripheral Arterial 63 Spinal Implant 63 Long Lesion 63 Contrast Agents 63 Aliskiren 63 Skeletal Muscle 63 everolimus eluting 63 Prostate Biopsy 63 Circulatory Support 63 Oral Anticoagulant 63 Endometrial Ablation 63 Hematological Cancers 63 Ranolazine 63 Critically Ill Patients 63 Recurrent Stroke 63 Demonstrates Sustained 63 Significantly Improved 63 Thoracic Endoprosthesis 63 Chronic Hepatitis B 63 Cholesterol Drugs 63 PROMUS 63 Prospective Multicenter 63 Multicenter 63 Endeavor Resolute 63 Sirolimus Eluting Coronary Stent 63 Prostate Cancer Recurrence 63 Randomized Comparison 63 Blood Pressure Lowering 63 Allogeneic 63 CentriMag 63 Patients Suffering 63 Septic Shock 63 Lumbar Spine 63 Tyrosine Kinase Inhibitor 63 Transplant Rejection 63 IMPELLA 63 Chemoradiation 63 Stress Urinary Incontinence 63 multicenter multinational 63 Secondary Hyperparathyroidism 63 Antidepressants Linked 63 Oral Mucositis 63 Serious Infections 63 Relapsing Remitting Multiple Sclerosis 63 Candesartan 63 CT Angiography 63 Cordis Cypher 63 Epilepsy Drug 63 Mycophenolate Mofetil 63 Anticoagulant 63 Pivotal Phase 63 Coronary Artery Bypass Grafting 63 Disease Modification 63 Insulin Glargine 63 Bone Mineral Density 63 MGuard ™ 63 Randomized Phase III 63 Allergic Rhinitis 63 Dyslipidemia 63 Therapeutic Potential 63 Single Dose 63 Clot Busting 63 Diabetic Kidney Disease 63 Invasive Fungal Infections 63 Is Well Tolerated 63 Implantable Device 63 Prostate Surgery 63 Hip Implants 63 Synthetic Peptide 63 Central Venous Catheters 63 Plaque Psoriasis 63 Gastrointestinal Disorders 63 Ovarian Cancer Patients 63 paclitaxel eluting 63 Osteoarthritis Patients 63 Prostatectomy 63 Platinum Chromium 63 Stem Cell Treatment 63 Endeavor drug eluting 63 Metastatic Renal Cell Carcinoma 63 Biphasic 63 Regimens 63 Combo Therapy 63 Testosterone Patch 63 ™ Everolimus Eluting 63 Metastatic Colorectal Cancer 63 Diabetic Neuropathy 63 Contrast Enhanced 63 Imaging Technique 63 Tesamorelin 63 Preclinical Study 63 Diastolic Heart Failure 63 FDA Clearance 63 Implantable Cardiac 63 Significantly Reduced 62 Male Contraceptive 62 Rotavirus Vaccine 62 Bone Fracture 62 Medtronic CoreValve ® 62 Novel Therapies 62 BioElectronics Announces 62 Oral Presentations 62 Unresectable 62 Statin Drugs 62 Unmet Medical 62 Severe Asthma 62 Advanced Melanoma 62 CABG Surgery 62 Blood Clots 62 Announces FDA Clearance 62 Technological Advances 62 TAXUS Express2 62 Combination REOLYSIN R 62 Confirmatory Phase 62 Prophylactic Treatment 62 Hospitalized Patients 62 Tiotropium 62 Autologous 62 Double Blind Randomized 62 Predict Risk 62 Knee Replacement Surgery 62 Colorectal Cancers 62 HepaSphere 62 Recombinant Human 62 Left Atrial 62 Acne Drug 62 Renal Function 62 everolimus eluting stent 62 Antimicrobial Coating 62 Oral Insulin 62 Sipuleucel T 62 Observational Study 62 Preterm Delivery 62 Guideline Update 62 Progenitor Cells 62 Asthma Treatment 62 Dose Reduction 62 Transdermal Patch 62 Insulin Delivery 62 Phase IIIb 62 Treatment Naive Patients 62 Nonalcoholic Steatohepatitis 62 Randomized Double Blind 62 Fibromyalgia Pain 62 Placebo Controlled Study 62 Recurrent Glioblastoma 62 Cardiac Function 62 Autologous Stem Cell Transplantation 62 Diabetic Foot Ulcer 62 Effectively Treats 62 Gastrointestinal Stromal Tumors 62 HEART FAILURE 62 Lung Injury 62 Anti Bacterial Envelope 62 Submits NDA 62 Lung Cancer Drug 62 Treatment Regimens 62 Nymox NX 62 Coherex FlatStent 62 Excessive Sweating 62 Renal Failure 62 Anemia Drug 62 Trial Evaluating 62 Ureteral 62 Receives Orphan Drug Designation 62 Varicose Veins 62 Anti Inflammatory Drugs 62 IND Application 62 Autoimmune Disease 62 Endoluminal 62 Demonstrates Efficacy 62 Decompensated Heart Failure 62 Monotherapy 62 Risk Stratification 62 Clinical Outcomes 62 Drug Prevents 62 Prolongs Life 62 Metastatic Melanoma 62 Parenteral Nutrition 62 Insulin Sensitivity 62 Infliximab 62 Migraine Headaches 62 HCV Protease Inhibitor 62 Cobalt Chromium 62 Left Ventricular Hypertrophy 62 Orthostatic Hypotension 62 Sustained Reduction 62 Blood Glucose Meters 62 Postmenopausal Osteoporosis 62 Blood Thinner 62 Interferon beta 1a 62 Novel Compound 62 Cancer Treatments 62 Surgical Mesh 62 Gets FDA Clearance 62 Clopidogrel 62 Microspheres 62 Device Helps 62 Double Blind Placebo 62 Brain Aneurysms 62 Arterial Disease 62 Bone Marrow Cells 62 TELIGEN 62 Critical Limb Ischemia 62 Myelodysplastic Syndromes 62 Vertebral Compression Fracture 62 Antipsychotic Drugs 62 Investigational Drug 62 Zenvia Phase III 62 Drug Candidate 62 Coronary Syndromes 62 Pirfenidone 62 Postmenopausal 62 Male Infertility 62 Image Guided 62 Lipid Lowering 62 Zoledronic Acid 62 Beta Blockers 62 Myeloma Patients 62 Myocardial Ischemia 62 Dose Ranging Study 62 Lowers Risk 62 Artificial Disc 62 Cholesterol Lowering Drugs 62 Heart Transplantation 62 Emboshield 62 Kidney Transplants 62 PHASE III 62 Kidney Transplant Recipients 62 Drug Combo 62 Fixed Dose 62 GORE VIABAHN ® 62 Balloon Angioplasty 62 Breast Reconstruction 62 Cholesterol Levels 62 Targeted Therapy 62 Advanced Renal Cell 62 Generic Version 62 Treat Heart Failure 62 Chronic Inflammation 62 drug eluting coronary stents 62 Beneficial Effects 62 XIENCE PRIME TM 62 zotarolimus eluting stent 62 XIENCE TM 62 Percutaneous 62 Genes Linked 62 Stress Incontinence 62 Clinical Relevance 62 Hsp# Inhibitor 62 Renal Anemia 62 Pulse Oximetry 62 Dapagliflozin 62 Cellulite Reduction 62 ADHD Medication 62 Lung Tumors 62 Blood Pressure Reduction 62 Heart Failure Treatment 62 Novel Mechanism 62 Hip Replacement 62 Adult Stem Cell Therapy 62 Bazedoxifene 62 Warfarin Coumadin 62 Cryoablation 62 Coronary stents 62 Hormone Refractory Prostate Cancer 62 Cilostazol 62 Alternative Treatments 62 Minimally Invasive 62 Interferon Alpha 62 STRIDE PD 62 Heart Failure Therapies 62 TAXUS Liberte Long 62 Hip Replacement Surgery 62 Receives FDA Clearance 62 Anti Tumor 62 Lymph Nodes 62 Showed Significant 61 Intra Arterial 61 HER2 Positive 61 Intravitreal 61 Study Demonstrates 61 Peripheral Artery Disease 61 Slow Progression 61 Lupus Drug 61 Chronic Myeloid Leukemia 61 Biolimus A9 61 Adjunctive 61 multicenter prospective 61 FDA Okays 61 Corneal Transplant 61 Stent Graft 61 Neoadjuvant 61 MEDTRONIC 61 Tryton Side Branch 61 Elagolix 61 Knee Arthritis 61 Sleep Disturbances 61 Blood Thinners 61 Wound Closure Devices 61 RE MODEL 61 Surgical Ablation 61 Intraocular 61 CYPHER SELECT TM 61 Slows Progression 61 Hemolysis 61 Androgen Deprivation Therapy 61 Tumor Growth 61 XIENCE V Everolimus Eluting 61 Shows Promise Against 61 STARFlex R 61 Cardiometabolic 61 Advanced Prostate Cancer 61 Liver Metastases 61 Nephrectomy 61 REALISM 61 Drug Fails 61 Tumor Response 61 Boosts Survival 61 Phase 2b Trial 61 GORE VIABAHN Endoprosthesis 61 Peripheral Arterial Disease 61 RENAL 61 Hepatitis C Treatment 61 Erectile Dysfunction Drug 61 Reduce Mortality 61 Anthracycline 61 Soft Tissue 61 Elevated Levels 61 Preterm Infants 61 Lenalidomide 61 Glycemic Control 61 Valvular 61 Castration Resistant Prostate Cancer 61 Nicotine Vaccine 61 Microplasmin 61 J Am Coll 61 Everolimus Eluting Coronary Stent 61 Molecular Mechanism 61 Transdermal Delivery 61 ENDEAVOR IV 61 Sustained Release 61 Vascular Grafts 61 Anticancer Drug 61 Tigecycline 61 VIVUS Qnexa 61 PFO closure 61 Menopausal Women 61 Regenerative Cell 61 Late Breaker 61 Spinal Fractures 61 Amniotic Fluid 61 Previously Untreated 61 Embolic Protection System 61 Mylan Receives Approval 61 Therapy Shows Promise 61 Relieve Pain 61 Covered Stent 61 Cardiovascular Prosthetic Devices 61 Adjunctive Therapy 61 Platelet Aggregation 61 Complication Rates 61 Bypass Surgery 61 Catheter System 61 Genetic Markers 61 Coronary Artery Calcium 61 ATS Simulus R 61 Migraine Treatment 61 Portal Hypertension 61 CYPHER ® Sirolimus eluting 61 Myocardial Infarction 61 Catheters 61 Gene Linked 61 Gene Variants 61 Treatment Reduces 61 Organ Rejection 61 Metabolic Disorder 61 Therapeutic Targets 61 Compression Therapy 61 Antipsychotic 61 Afib 61 Lubiprostone 61 Bone Marrow Transplants 61 Arthritis Drugs 61 Efficacy Trial 61 Pneumococcal Vaccine 61 Proven Effective 61 Polyzene R F 61 Sirolimus 61 Benign Prostatic Hyperplasia BPH 61 coronary stent merged 61 Breast Biopsy 61 Implantation 61 Often Misdiagnosed 61 Brain Scans 61 Adult Stem Cells 61 Adalimumab 61 Inflammatory Markers 61 Back Pain Sufferers 61 carotid artery stenting CAS 61 Ablation System 61 Combination Therapy 61 Treatment Algorithm 61 Endovascular Graft 61 INFUSE ® 61 Lower Extremity 61 Aggressive Reduction 61 thrombus aspiration 61 Cancer Recurrence 61 eluting stent 61 IN PATIENTS WITH 61 Cyclooxygenase 2 61 ReoPro 61 Desvenlafaxine Succinate 61 Congestive Heart Failure 61 Hip Resurfacing 61 Lowering Blood Pressure 61 Drug eluting stent 61 Teva Provides Update 61 Effective Than 61 Metabolic Endocrinology 61 Acute Coronary 61 Glaucoma Treatment 61 Novacor R 61 Ultrasound Imaging 61 carotid stenting 61 Fat Grafting 61 Arthritis Drug 61 Metastatic Pancreatic Cancer 61 Placebo Effect 61 Heparin Bioactive Surface 61 Genes Predict 61 Atrial Fibrillation Treatment 61 Files IND 61 Genetic Variations 61 Tolerability 61 Cancer Vaccines 61 BioSTAR R 61 Herbal Supplements 61 PICSO ® 61 Bloodstream Infections 61 Androgen Deprivation 61 urethral bulking agent 61 Direct Visualization 61 Stem Cell Transplants 61 Adipose Derived Stem Cells 61 Hormone Replacement 61 Artificial Pancreas 61 Diagnostic Tools 61 ASTEROID 61 Tezampanel 61 Self Expanding Stent 61 Preclinical Models 61 Gene Mutation 61 Aggressive Prostate Cancer 61 Genetic Variant 61 oral anticoagulants 61 Pivotal Trials 60 Inhaled Steroids 60 Pain Relievers 60 FDA Panel Recommends 60 Testosterone Gel 60 Bone Grafts 60 Symptom Relief 60 Adverse Outcomes 60 Endovascular System 60 Achieves Primary Endpoint 60 Inflammatory Disease 60 carotid artery stenting 60 Treatment Experienced 60 Dupuytren Contracture 60 Non Responders 60 Oral Cavity 60 Thrombotic 60 Extended Release 60 Mortality Risk 60 Uterine Fibroids 60 Safinamide 60 Artificial Cornea 60 Potentially Fatal 60 Magnetic Nanoparticles 60 Phase Ib Clinical Trial 60 Guidelines Recommend 60 Ablation 60 Multicenter Phase 60 phase IIIb 60 Diabetic Neuropathic Pain 60 Peripheral Vascular Disease 60 Chemotherapy Regimen 60 Significantly Reduces 60 Controlled Study 60 Cardiac Defibrillators 60 sirolimus eluting stents 60 Breast Cancer Patients 60 Bevacizumab 60 Reduces Pain 60 Refractory Hodgkin Lymphoma 60 Neoplasms 60 FDA Accepts 60 Systemic Delivery 60 Inhalation Solution 60 Pharmacodynamics 60 Fidaxomicin 60 SYNTAX 60 Medication Errors 60 Cardiac Arrest Patients 60 Diabetic Macular Edema 60 Left Ventricular Dysfunction 60 Augment TM 60 Surgical Technique 60 PresbyLens ® 60 Knee Replacements 60 Pertuzumab 60 Ovarian Tissue 60 Vaginal Gel 60 Femoral 60 Randomized Phase 60 Smooth Muscle 60 Advanced Ovarian Cancer 60 saphenous vein graft 60 Randomised 60 Epoetin Alfa 60 multicentre randomized 60 Femtosecond Laser 60 Prognostic Significance 60 Diabetic Nephropathy 60 Malignant Glioma 60 Stem Cell Procedure 60 Novel Oral 60 Spinal Fluid 60 Cancer Therapies 60 CYPHER R Sirolimus eluting 60 Multicenter Randomized 60 Invasive Breast Cancer 60 Nonsurgical 60 Biliary System 60 Depressive Symptoms 60 Vertebral Fractures 60 MGuard 60 Peginterferon 60 LEUKINE 60 Clostridium difficile Infection 60 Annuloplasty 60 Blood Clotting 60 Antithrombotic 60 Capsules CII 60 Treatment Options 60 Acute Pancreatitis 60 Initiates Clinical Trial 60 Levels Linked 60 Viral Infections

Back to home page